ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results for ILUVIEN in Diabetic Macular Edema

ANI Pharmaceuticals announced results from the NEW DAY clinical trial evaluating ILUVIEN (fluocinolone acetonide intravitreal implant) for diabetic ma...
Home/KnloSights/Clinical Trial Updates/ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results for ILUVIEN in Diabetic Macular Edema